Página 3 - Melhores Câncer uterino médicos - TOP-101 médicos

Diretor de Hospitalização Oncológica no Tel Aviv Medical Center (Ichilov). O Dr. Stepfansky traz profunda experiência no tratamento de casos complexos de cancro do útero.

• Especialista em oncologia com mais de 19 anos de experiência
• Investigador principal em vários ensaios clínicos sobre novos tratamentos de cancro
• Formação especializada no Ichilov – um dos principais centros de oncologia de Israel

O Dr. Topcu é especialista no tratamento do cancro do útero, com vasta formação internacional em centros oncológicos de renome como o MD Anderson e o Moffit.

• Especialista em oncologia médica com mais de 15 anos de experiência
• Formado no MD Anderson Cancer Center e no Sunnybrook Odette Cancer Center
• Especialista em cancros ginecológicos, incluindo útero e ovário
• Trabalha nos Valued Med Hub Hospitals

O Dr. Alemdar é especializado em cancro uterino, com vasta formação em oncologia médica pela Universidade de Akdeniz.

• Mais de 15 anos de experiência em oncologia
• Formado na Universidade de Akdeniz, uma instituição médica de renome
• Trabalhar no Complexo Hospitalar Medical Park Antalya

Especialista em cancros urogenitais com foco em tratamentos baseados em investigação – O Dr. Sec atua como Representante dos Médicos Especialistas da Associação Turca de Oncologia Médica.

• Mais de 5 anos de experiência em oncologia médica
• Publicar vários estudos sobre os resultados do tratamento do cancro
• Membro da Associação Turca de Oncologia Médica
• Trabalhar no Hospital Bahçelievler Medikalpark

O Dr. Yildiz publicou extensivamente sobre oncologia ginecológica, incluindo pesquisas sobre cancro do endométrio e síndromes paraneoplásicas.

• Coautorar estudos sobre os efeitos do acetato de megestrol no cancro do endométrio
• Publicar relatos de casos sobre apresentações raras em oncologia ginecológica
• Ser membro de equipas de investigação que investigam novos tratamentos oncológicos
• Trabalhar no departamento de oncologia do Hospital Universitário Medipol Mega

O Dr. Rabin coordena o tratamento de câncer no Hospital Sheba de Tel Hashomer e formou-se no renomado MD Anderson Cancer Center.

• Concluir residência em oncologia e radioterapia
• Fellowship em oncologia ginecológica no MD Anderson
• Vasta experiência no tratamento de tumores do sistema reprodutor feminino
• Investigador em pesquisas inovadoras de ablação por ultrassom guiada por RM
• Membro da American Society for Radiation Oncology

O Prof. Dr. Wolfgang Köstler é um oncologista de renome, especializado em cancros ginecológicos, com mais de 20 anos de experiência na Wiener Privatklinik.

• Especialista em terapias direcionadas para o cancro do útero
• Subchefe da Divisão Clínica de Oncologia da Universidade de Medicina de Viena
• Investigador com publicações em desenvolvimento de biomarcadores e biologia tumoral
• Focar-se na terapia oncológica sistémica individualizada e na imunoterapia

O Professor Associado Tahsin Ozatli é especialista em cancros da mama, do pulmão e gastrointestinais no Hospital Universitário Istinye Liv.

• Mais de 10 anos de experiência em oncologia
• Formação na Faculdade de Medicina da Universidade de Selcuk
• Trabalhou anteriormente na Clínica de Oncologia de Ancara
• Promovido a Professor Associado em 2016

O Prof. Cemil Bilir é especializado em cancro uterino, com dupla experiência em oncologia médica e investigação em química inorgânica.

• Mais de 18 anos em oncologia com formação subespecializada na Cleveland Clinic
• Professor na Universidade de Sakarya – líder no ensino da oncologia
• Membro da ASCO, ESMO e da Sociedade Turca de Oncologia Médica
• Realizar investigação sobre o cancro paralelamente à prática clínica

O Prof. Associado Nail Paksoy é especializado no tratamento do cancro do útero no Hospital Medipol Bahçelievler, com vasta investigação em oncologia ginecológica.

• Certificado pelo Conselho da ESMO em Oncologia Médica
• Publicar múltiplos estudos sobre tratamentos de cancro do endométrio
• Participar em ensaios clínicos internacionais para cancro do endométrio avançado
• Realizar formação de especialização no Instituto de Oncologia da Universidade de Istambul

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.

A Dra. Inta Jaunalksne é especialista em viroterapia, uma área de ponta da imunologia, com mais de 30 anos de experiência.

• Chefe do Centro de Imunologia Clínica do Hospital Universitário Clínico Pauls Stradins
• Graduada pelo Instituto Médico de Riga com estágio em Medicina Interna
• Focar em tratamentos imunológicos inovadores

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

O Dr. Ozden traz mais de 20 anos de experiência médica, especializando-se em oncologia com foco em cancro do útero no Hospital VM Medical Park Pendik.

• Licenciar-se na prestigiada Faculdade de Medicina Cerrahpaşa da Universidade de Istambul
• Concluir a subespecialidade de Oncologia Médica na Universidade de Kocaeli
• Vasta experiência em ambientes hospitalares públicos e privados
• Praticar medicina interna antes de se especializar em oncologia

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.